The extensions of the approval periods of the active substances flubendiamide, L-ascorbic acid, spinetoram and spirotetramat, are no longer justified according to the Commission (Implementing Regulation (EU) 2020/2007). Therefore the expire date for spirotetramat, has been set to 30 April 2024, for L-ascorbic acid and spinetoram has been set to 30 June 2024, and for flubendiamide has been set to 31 August 2024.
These amendments have been already implemented in Homologa®. Visit Homologa® or contact us for more details.